Holen Sie sich die Stockscreener-App
247.46
3.62%
8.64
Handel nachbörslich:
247.50
0.04
+0.02%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$238.82
Offen:
$237.09
24-Stunden-Volumen:
2.62M
Relative Volume:
1.37
Marktkapitalisierung:
$37.37B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$853.00M
KGV:
44.91
EPS:
5.5097
Netto-Cashflow:
$556.00M
1W Leistung:
+11.32%
1M Leistung:
+12.79%
6M Leistung:
+99.03%
1J Leistung:
+143.83%
1-Tages-Spanne:
$234.57
$248.16
1-Wochen-Bereich:
$223.70
$250.06
52-Wochen-Spanne:
$88.00
$250.06
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
247.46 | 31.17B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
658.52 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.09 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.90 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.26 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.09 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
Illumina Inc. stock gains support from UBS upgrade and raised 2026 outlook - ad-hoc-news.de
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Illumina (NASDAQ: ILMN) CLO grants may pay up to 250% of target shares - Stock Titan
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Advancing whole-genome sequencing with long-range data - News-Medical
Illumina stock heads into the open after a 2.1 percent slip - ad-hoc-news.de
Illumina CTO Steven Barnard Sells 408 Shares at $211.06 Each - Kalkine Media
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina (NASDAQ: ILMN) insider still holds 40,927 shares - Stock Titan
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now - Zacks Investment Research
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Dear Illumina Stock Fans, Mark Your Calendars for September 21 - Barchart.com
UBS Upgrades Illumina to Buy From Neutral, Adjusts Price Target to $260 From $135 - marketscreener.com
3 Stocks Soon Joining the S&P 500 - TradingView
A Look at Illumina Inc (ILMN) After 3.3% Decline -- GF Value $13 - GuruFocus
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Responsive Playbooks and the ILMN Inflection - Stock Traders Daily
Bloom Energy Joins the S&P 500 as The Trade Desk Leaves - TradingView
Illumina: Priced For Perfection It Hasn't Earned Yet (NASDAQ:ILMN) - Seeking Alpha
Bloom Energy, Everpure, Illumina to Join S&P 500 in September Rebalance - marketscreener.com
Illumina Inc. stock gains on S&P 500 re-entry and strong earnings - ad-hoc-news.de
Illumina and Everpure to Join S&P 500 in September Rebalancing: What it Means for Investors - Yahoo Finance
Illumina (ILMN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Illumina, a "pick company" of deoxyribonucleic acid (DNA) research, succeeded in re-establishing it - 매일경제
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Amid Market Volatility - DirectorsTalk Interviews
The Trade Desk to leave S&P 500 as Bloom Energy, Everpure, Illumina join index - Seeking Alpha
Illumina Inc. stock gains on S&P 500 inclusion and collaboration news - ad-hoc-news.de
Illumina joins S&P 500 as Bloom Energy, Everpure also added - Financial-News.co.uk
Illumina (ILMN) Stock Looks Priced For Growth More Than Value - Yahoo Finance
Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards - Matlabi News
Bloom Energy, Illumina, and Everpure set to join S&P 500 in quarterly rebalance - investing.com
Illumina director Keith Meister sells $57.2 million in stock By Investing.com - Investing.com South Africa
Could Illumina’s Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)? - Yahoo Finance
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 - Investing News Network
Illumina director Keith Meister sells $57.2 million in stock - Investing.com
Bloom Energy, Illumina, Everpure to Join S&P 500 in September Rebalance - finance.biggo.com
Bloom Energy, Illumina, Everpure To Join S&P 500 - marketscreener.com
Director-linked funds sell Illumina (NASDAQ: ILMN) shares without preset plan - Stock Titan
Bloom Energy, Illumina and Everpure set to join S&P 500 before Sept. 21 open - Briefs Finance
Bloom Energy surges on inclusion to S&P 500; Illumina, Everpure also added (BE:NYSE) - Seeking Alpha
Bloom Energy, Illumina, Everpure to Join S&P 500 This Month - Bloomberg.com
Illumina’s S&P 500 Return Adds $704 Million After Hours - ts2.tech
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
S&P 500 Index Faces Quarterly Reshuffle: Bloom Energy (BE.US) Stands Out Thanks to AI Computing Power Demand, Illumina (ILMN.US) and Everpure (P.US) Included - Bitget
Illumina Inc (ILMN) Stock Up 3.9% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
The Market Just Told You Which Layer Of AI Biology It Is Paying For - Investing News Network
Beyond the Human Genome Project: What’s next for genomics? - Illumina
Pillar Biosciences Adds Illumina and ORI Capital Executives to Board - citybiz.co
Illumina Inc. stock falls despite strong rebound from mid-2025 lows - AD HOC NEWS
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Illumina Inc-Aktie (ILMN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Meister Keith A. | Director |
Sep 03 '26 |
Sale |
218.23 |
75,951 |
16,574,481 |
889,851 |
| Meister Keith A. | Director |
Sep 02 '26 |
Sale |
213.28 |
68,108 |
14,526,254 |
965,802 |
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):